Scott Dunseth Myers - Director at Cartesian Therapeutics, Inc.

Issuer-level insider activity

Role
Director
Issuer symbol
RNAC on Nasdaq
Identity 1 identity field
Entity type
Individual
Source evidence 1 source field
SEC filing history
Open SEC filing history

No buys or sells have been reported by Scott Dunseth Myers since 02 Jun 2025

Reported holdings for Scott Dunseth Myers in Cartesian Therapeutics, Inc.

Form 4 holding Director

Cartesian Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
13 Nov 2023
Price
$0.7900
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Scott Dunseth Myers in Cartesian Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .